Marongiu Giuseppe, Contini Andrea, Cozzi Lepri Andrea, Donadu Matthew, Verona Marco, Capone Antonio
Orthopaedic and Trauma Clinic, Department of Surgical Sciences, University of Cagliari, 09124 Cagliari, Italy.
Orthopaedic Traumatologic Center, University of Florence, 50121 Florence, Italy.
Bioengineering (Basel). 2020 Feb 24;7(1):22. doi: 10.3390/bioengineering7010022.
The healing of long bones diaphyseal fractures can be often impaired and eventually end into delayed union and non-union. A number of therapeutic strategies have been proposed in combination with surgical treatment in order to enhance the healing process, such as scaffolds, growth factors, cell therapies and systemic pharmacological treatments. Our aim was to investigate the current evidence of bone healing enhancement of acute long bone diaphyseal fractures.
A systematic review was conducted by using Pubmed/MEDLINE; Embase and Ovid databases. The combination of the search terms "long-bones; diaphyseal fracture; bone healing; growth factors; cell therapies; scaffolds; graft; bone substitutes; orthobiologics; teriparatide".
The initial search resulted in 4156 articles of which 37 papers fulfilled the inclusion criteria and were the subject of this review. The studies included 1350 patients (837 males and 513 females) with a mean age of 65.3 years old.
General lack of high-quality studies exists on the use of adjuvant strategies for bone healing enhancement in acute shaft fractures. Strong evidence supports the use of bone grafts, while only moderate evidence demineralized bone matrix and synthetic ceramics. Conflicting results partially supported the use of growth factors and cell therapies in acute fractures. Teriparatide showed promising results, particularly for atypical femoral fractures and periprosthetic femoral fractures.
长骨干骨折的愈合常常会受到影响,最终导致延迟愈合和不愈合。为了促进愈合过程,已经提出了多种与手术治疗相结合的治疗策略,如支架、生长因子、细胞疗法和全身药物治疗。我们的目的是研究目前关于增强急性长骨干骨折骨愈合的证据。
通过使用PubMed/MEDLINE、Embase和Ovid数据库进行系统评价。检索词组合为“长骨;骨干骨折;骨愈合;生长因子;细胞疗法;支架;移植物;骨替代物;骨科生物制剂;特立帕肽”。
初步检索得到4156篇文章,其中37篇符合纳入标准,为本综述的主题。这些研究包括1350例患者(男性837例,女性513例),平均年龄65.3岁。
在急性骨干骨折中,关于使用辅助策略促进骨愈合的高质量研究普遍缺乏。有力证据支持使用骨移植,而对于脱矿骨基质和合成陶瓷仅有中等证据。相互矛盾的结果部分支持在急性骨折中使用生长因子和细胞疗法。特立帕肽显示出有前景的结果,特别是对于非典型股骨骨折和假体周围股骨骨折。